Susan Hasty, Publisher
Table of Contents . . . January 29th, 2001
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Pharmacokinetics - Pegylated Interferon-alpha Therapy Profiled for Chronic Hepatitis C Patients
Disease Associations - Hepatitis C Patients with Kidney Disease See Limited Relief with Interferon
Disease Associations - Non-Specific Route Lines Path to Hepatocellular Carcinoma in Hepatitis B and C
Hemodialysis - High-Biocompatible Filters Reduce Hepatitis C Transmission Risk
Hepatocellular Carcinoma - Interferon Receptors on Liver Tissues are Up-Regulated by Inflammatory Cytokines
Immunization - Organization Uses Different Approach to Increase Hepatitis Vaccine Awareness
Kidney Transplantation - Liver Function Tests Parallel Liver Appearance after Transplantation
Liver Cancer - Cells in Diabetic Mice Resist Tumor Necrosis Factor Induced Lethality
Liver Transplantation - Apoptosis, Liver Injury More Common in Genotype Ib Hepatitis C Post-Transplant
Pathogenesis - Progenitor Cells Relocate to Uncommon Areas of Inflamed Livers
Pathology - Serum ALT Values Important but Don't Tell Full Story of Liver Disease
Therapy (HCV) - Pivotal U.S. Phase III Program Begins with Zadaxin Plus Pegylated Alfa Interferon
Blood Safety - PAHO Grants Funds to Improve Transfusion Safety
Immunization - CDC Adds Another Vaccine to Children's Schedule of Shots
Immunization - Hepatitis B Program in Hawaiian Schools Increases Vaccine Rate
Immunization - Study Finds Hepatitis B Vaccination Policies Inconsistent in Colorado
Immunology - Personality Trait May Influence Immune System Response
Liver Cancer - Possible Link Made to Fatty Acids and Growth Factor Binding Proteins
Therapy (HBV) - Ribozyme Targets Hepatitis B RNA Transcripts
Tissue Engineering - FDA Proposes New Rules for "Good Tissue Practice"
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.